Science Explorer Back to mapMap
Discussion
Researcher · Centre Georges François Leclerc · France

Nicolás Isambert

Nicolás Isambert publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Sarcoma Diagnosis and Treatment, Gastrointestinal Tumor Research and Treatment and Lung Cancer Treatments and Mutations.

ORCID 0000-0003-3596-2114 OpenAlex
World rank
#126,671
of 7,710,434 ranked researchers
Rank in France
#9,494
of 324,115
Works
449
Citations
15k
Citations per work
32.9
h-index
63
i10-index 160Top 1.9% in Oncology
Nicolás Isambert

What does Nicolás Isambert research?

Nicolás Isambert's work is mostly in Medicine (52%), Biochemistry, Genetics and Molecular Biology (9%), Chemistry (4%).

Health Sciences: 234 works · 52.1% of their workMedicine: 234 works · 52.1% of their workOncology: 99 works · 22.0% of their workPulmonary and Respiratory Medicine: 92 works · 20.6% of their workSurgery: 22 works · 5.0% of their workGastroenterology: 20 works · 4.5% of their workEverything else: 155 works · 34.6% of their workLife Sciences: 40 works · 8.8% of their workBiochemistry, Genetics and Molecular Biology: 40 works · 8.8% of their workMolecular Biology: 40 works · 8.8% of their workPhysical Sciences: 20 works · 4.5% of their workChemistry: 20 works · 4.5% of their workOrganic Chemistry: 20 works · 4.5% of their workTHEIR WORKNicolás Isambert449works
Life Sciences9%Physical Sciences4%Health Sciences52%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine23452.1%
  2. Everything else15534.6%
    1. Biochemistry, Genetics and Molecular Biology408.8%
    1. Chemistry204.5%
  1. 1Oncology22% of their works
  2. 2Pulmonary and Respiratory Medicine21% of their works
  3. 3Molecular Biology9% of their works
  4. 4Surgery5% of their works
  5. 5Gastroenterology4% of their works
  6. 6Organic Chemistry4% of their works

Research topics

Which keywords describe Nicolás Isambert's research?

The keywords of their largest research topics: Prognostic Factors, Chemotherapy, Osteosarcoma, Soft Tissue Sarcoma, Imatinib Mesylate, Sunitinib, EGFR Mutations and Targeted Therapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Prognostic Factors1572 topics
  2. Chemotherapy1402 topics
  3. Osteosarcoma1111 topic
  4. Soft Tissue Sarcoma1111 topic
  5. Imatinib Mesylate461 topic
  6. Sunitinib461 topic
  7. EGFR Mutations411 topic
  8. Targeted Therapy411 topic
  9. Angiosarcoma381 topic
  10. Epithelioid Hemangioendothelioma381 topic
  11. Chemotherapy-Induced Peripheral Neuropathy331 topic
  12. Taxanes331 topic
  13. Cardiac Tumors321 topic
  14. Immune Checkpoint Blockade321 topic
  15. PD-1 and PD-L1321 topic
  16. PRKAR1A Gene Mutations321 topic
  17. Cetuximab291 topic
  18. KRAS Mutations291 topic

Where does Nicolás Isambert work?

Nicolás Isambert's main affiliation in the publication record is Centre Georges François Leclerc, France.

How many publications and citations does Nicolás Isambert have?

OpenAlex counts 449 works and 14,753 citations for Nicolás Isambert, an h-index of 63, ranking #126,671 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Nicolás Isambert. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.